nonat develops medical AI foundation models focused on women’s and children’s health, with an initial research emphasis on preterm birth, stillbirth, and neonatal mortality. The company was founded by three physicians in 2023 and has completed multiple clinical research PoCs since inception. nonat plans to use the new funding to improve model generalization and data quality, strengthen hiring in clinical research and R&D, and expand multi‑institutional collaborative studies with national universities. The company operates from a head office in Gifu and maintains a Tokyo lab in Shibuya. nonat is recruiting globally to accelerate its research and development efforts. With the recent Pre‑Series A funding, it intends to scale its technology and partnerships to advance its “Generations as a Service” vision.

Total raised

$1M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2025